Showing results (1-10 of 9,577) with videos related to
Sort By:
Pageof 958
American Heart Journal|July 15, 2020
Rationale and design of the RIGHT trial: A multicenter, randomized, double-blind, placebo-controlled trial of anticoagulation prolongation versus no anticoagulation after primary percutaneous coronary intervention for ST-segment elevation myocardial infarctionYan Yan, Xiao Wang, Jincheng Guo, et al.Cardiovascular Therapeutics|January 25, 2021
New Clinical Classification for Ventricular Free Wall Rupture following Acute Myocardial InfarctionWei Gong, Shaoping NieJACC. Cardiovascular Interventions|February 11, 2022
Postprocedure Anticoagulation in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary InterventionYan Yan, Wei Gong, Changsheng Ma, et al.Frontiers in Cardiovascular Medicine|April 7, 2022
Clinical Characterization and Possible Pathological Mechanism of Acute Myocardial Injury in COVID-19Siyi Li, Jinan Wang, Yan Yan, et al.Journal of the American College of Cardiology|November 3, 2022
Risk Factors for In-Hospital Cardiac Arrest in Patients With ST-Segment Elevation Myocardial InfarctionWei Gong, Yan Yan, Xiao Wang, et al.Frontiers in Cardiovascular Medicine|September 27, 2021
Secreted Frizzled-Related Protein 5 Protects Against Cardiac Rupture and Improves Cardiac Function Through Inhibiting Mitochondrial DysfunctionXin Huang, Yan Yan, Wen Zheng, et al.Journal of Cardiovascular Translational Research|January 26, 2021
Phosphodiesterase-5a Knock-out Suppresses Inflammation by Down-Regulating Adhesion Molecules in Cardiac Rupture Following Myocardial InfarctionSiyi Li, Youcai Ma, Yan Yan, et al.JACC. Asia|May 22, 2026
Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention: 1-Year Results From the RIGHT Trial and Meta-analysesYan Yan, Xiao Wang, Zeyuan Fan, et al.International Heart Journal|July 21, 2020
Clinical Manifestation, Timing Course, Precipitating Factors, and Protective Factors of Ventricular Free Wall Rupture Following ST-Segment Elevation Myocardial InfarctionWei Gong, Han Shi, Mengwen Yan, et al.Journal of Cardiovascular Pharmacology|November 29, 2023
Pde5 Inhibition Reduced Blood Pressure and Alleviated Target Organ Damage in Chronic Intermittent HypoxiaSiyi Li, Qingjie Xin, Yan Yan, et al.Pageof 958